SPEECH BY MR ONG YE KUNG, MINISTER FOR HEALTH AND COORDINATING MINISTER FOR SOCIAL POLICIES, AT THE NATIONAL INFECTION PREVENTION & CONTROL HEALTHCARE CONFERENCE 2026, 16 NOVEMBER 2026
16 November 2026
Professor Vernon Lee, Chief Executive Officer, Communicable Diseases Agency
Distinguished guests, ladies and gentlemen
1. I am happy to join you today at the National Infection Prevention and Control (IPC) Healthcare Conference.
Infectious Diseases Remain a Priority
2. Infectious diseases – the plague, cholera, malaria, tuberculosis, polio, measles, HIV, and many more – have preoccupied public healthcare for much of modern human history. They were a key cause of premature deaths. Hence, healthcare systems have always been focused on managing these diseases and their impact, and the key indicators of success were infant mortality and lifespan.
3. Modern sanitation, vaccines and medical advances have delivered much success. Infant mortality rates fell and lifespans lengthened. Today, we are transiting into a new era where the main challenge is
non-communicable diseases such as cancer, dementia, diabetes and hypercholesterolaemia. Our key indicator of success, you can see it gradually it is becoming not just lifespan, but also health span, a gap between the two.
4. That said, infectious diseases remain a key pre-occupation. The challenge is not over but has evolved.
Evolving Challenges
5. There are at least four impending challenges in our ongoing fight against infectious diseases.
6. First, antimicrobial resistance, or AMR. Antibiotics transformed medicine in the last century. Once-fatal infections became easily treatable, making modern surgery, chemotherapy and organ transplants possible. But bacteria evolve, and every inappropriate use of an antibiotic gives them an opportunity to strengthen and gain an advantage over humans.
7. For example, antibiotics do no good when they are prescribed for viral infections. They are also used on a massive scale in agriculture and livestock farming in many parts of the world, finding their way into our food, water and environment. All these practices enable bacteria to become more resistant.
8. For a patient infected with a bug resistant to all available antibiotics, you may have this experience, doctors may have nothing left to offer. The toll is mounting. A major study in The Lancet estimated that AMR directly caused 1.14 million deaths in 2021 and projected this to rise to almost 2 million a year by 2050. Eventually, hospitals that are meant to be places of healing risk becoming places of danger. So, if you look at the number of deaths, it is not smaller than, say, COVID-19
9. Second, climate change. As the planet warms, the map of disease is being redrawn. The Asian tiger mosquito, which spreads dengue and chikungunya, is now established in 16 European countries. Last year, France and Italy reported more than 1,100 locally acquired chikungunya cases, with transmission as far north as Alsace. West Nile virus is being detected in new parts of Europe almost every year. And in October last year, mosquitoes were found in the wild in Iceland for the first time. Diseases that we in the tropics have long lived with are becoming everyone’s problem.
10. Third, vaccine scepticism. Vaccines are among the greatest public health achievements in history. But scepticism, amplified by misinformation online, has come to the fore, especially after COVID-19. The consequences are real and dire.
11. Measles, declared eliminated in the United States in 2000, is making a strong comeback. The US recorded fewer than 300 cases in 2024, about 2,300 last year, and more than 4,500 so far this year. Canada lost its measles elimination status in November last year. With international air travel, this has heightened the risk everywhere in the world. Singapore also saw a slight uptick in measles, but mostly imported.
12. Advances in medical science, including mRNA technology, promise faster development of more effective vaccines. But so long as vaccine scepticism remains, it is a chink in our armour, potentially preventing us from achieving herd immunity, especially for highly contagious diseases like measles, where over 95% coverage is needed.
13. Fourth, the next pandemic. What we worry about most is another pandemic crisis like SARS or COVID-19, which is an evolutionary certainty. It will happen, just matter of when. With climate change, shrinking natural habitats, and diseases jumping from animals to humans more frequently than ever, the risk we face today is higher than it has ever been.
14. The experience of COVID-19 has led to many meaningful initiatives to help us be better prepared. National healthcare systems have fortified themselves, strengthened their IPC capabilities, and developed response plans. The Coalition for Epidemic Preparedness Innovations (CEPI) is working on developing safe and effective vaccines that can be ready within 100 days of a new pandemic threat being identified. During COVID-19, we had a vaccine in nine months, which is unprecedented, and now the project is to work towards 100 days. Countries are building up vaccine production capacity to avoid a repeat of the uneven vaccine distribution during COVID-19.
15. Since May, the Democratic Republic of the Congo (DRC) has been battling an Ebola outbreak caused by the Bundibugyo virus. It is now the second-largest Ebola outbreak on record, with more than 10,000 confirmed cases and close to 5,000 deaths. So, it is a very high case mortality rate of about half. Imported cases have since been detected in Kenya and Nigeria.
16. But science is fighting back. CEPI is backing several vaccine candidates against the Bundibugyo strain, and one of them is being developed in Singapore, through a collaboration with Hilleman Laboratories, a joint venture of MSD and Wellcome.
17. The race against the emergence of another deadly pathogen has started. We have science and international co-operation on our side, while the pathogens have misinformation, scepticism, fear and social disunity on their side.
The Road Ahead and Singapore’s Contribution
18. These challenges illustrate that infectious diseases continue to feature strongly on the health agenda. We must protect and build our global commons. And it is particularly important for infectious disease response because our collective ability to fight bacterial infections is one such commons, and we must now slow down and even reverse its depletion.
19. IPC is an important part of this effort, by preventing infections and reducing the need for antibiotics. We need to tighten discipline in the use of antibiotics – in hospitals, in the community and on farms – and create incentives for pharmaceutical companies to invest in developing effective new antibiotics, which today offer little commercial return.
20. We should share experiences on vector control and on managing diseases emerging due to climate change as well as find ways to lower temperatures in hospitals. Singapore, for one, has much to share from decades of fighting dengue, including through Project Wolbachia.
21. And we must recognise that scepticism is a natural reaction in times of uncertainty, when people are unsure about new diseases and new remedies they have never heard of, and are worried about the harms of modern technology. We should not dismiss it. What we need to do is to educate, be transparent with data, benefits and risks, and explain why vaccines are overall beneficial, especially in controlling the spread of diseases. You can never eliminate the very convinced vaccine sceptic, but I think we can prevent the large mass of the population from believing in what they say, and that we must do it through education, through transparency of data and information. That is our best chance of converting scepticism into acceptance and confidence.
22. Singapore will play its part, and has invested steadily in strengthening our national IPC capabilities – enhancing surveillance systems, establishing evidence-based guidelines, and developing close partnerships across our healthcare system.
23. Through the Singapore Cooperation Programme, which is Singapore’s primary platform for technical assistance and
capacity-building for developing countries, we regularly share Singapore’s experience in infectious disease prevention and management. To date, over 3,100 government officials from other countries have benefited from its public health courses. Many of you may be involved in these courses, so please support when there is one happening in your institution.
24. Our experts from the Communicable Diseases Agency and National Centre for Infectious Diseases are also contributing internationally through the Global Infection Prevention and Control Network, coordinated by the World Health Organization (WHO).
25. CDA has just been designated as a WHO Collaborating Centre for IPC, joining other centres in jurisdictions such as Hong Kong, the United Kingdom, Switzerland, Germany and Saudi Arabia. It will be the first Collaborating Centre dedicated to strengthening health systems through IPC. It will work closely with WHO and Member States in the Western Pacific Region, contributing in areas such as IPC policy and practice, infection surveillance, guideline development, and capability building.
Conclusion
26. In conclusion, infectious diseases have shaped human history, and they will continue to shape our future. The microbes will keep evolving; so must we. Much of this fight is won not just in laboratories or policy papers, but in wards, clinics and nursing homes – through hand hygiene, careful antibiotic use, early detection, disciplined practice, every single day. And our defences will be bolstered through international co-operation, learning from each other, and building the global commons that keep us all safe.
27. That is the work of everyone in this room. Thank you for being our first line of defence. I wish everyone a fruitful conference. Thank you.
